NCT05799898View on ClinicalTrials.gov

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

January 1, 2030

Conditions
CancerImmune Checkpoint InhibitorCardiovascular ComplicationImmune-related Adverse Event
Interventions
OTHER

No intervention for research purposes only

No intervention for research purposes only

Trial Locations (1)

75014

RECRUITING

Intitut Mutualiste Montsouris, Paris

All Listed Sponsors
lead

Institut Mutualiste Montsouris

OTHER